Which flavour of TIGIT will you choose?

The annual SITC meeting is coming up fast and it’s time for a new update on TIGIT since there are a raft of abstracts being presented in this niche, not to mention a variety of novel agents being developed from antibodies to bispecifics to fusion proteins in various shades as well as the potential for a number of diffferent combination partners.

With so many TIGIT flavours to choose from there’s plenty of new opportunities to explore and discuss…

BSB subscribers can read up on our ongoing commentary and analysis from the cancer conference season for our meeting coverage at SITC – you can either log-in or click to access our latest analysis.

This content is restricted to subscribers

Posted by